VERV DEADLINE: RLF, THE FIRST FILING FIRM, Encourages Verve Therapeutics, Inc. Investors With Losses in Excess of 100K ...
NEW YORK, Oct. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class …